Withdrawal
11
1
1
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (11)
Evaluation of the Electronic Cigarette Withdrawal Syndrome
Effect of Diuretics Withdrawal in Chronic Heart Failure with Reduced Ejection Fraction
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
The Biobehavioral Impact of Diet Quality on Affect and Craving
Evaluation of the Management of Tramadol Use Disorders
Feasibility of Auricular Acupressure as an Adjunct Treatment for Neonatal Abstinence Syndrome (NAS)
Opioid Physiology Project
Evaluation of the Effect of Venous Diameter Measurement by Ultrasonography on Pain and Withdrawal Response
Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study
Terminal Weaning of Mechanical Ventilation or Extubation in Anticipation of Death in the Intensive Care Unit